Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02437136
Brief Title: Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer

First Submitted : April 27, 2015
First Submitted that Met QC Criteria : May 4, 2015
First Posted : May 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 27, 2018
Last Update Posted : November 28, 2018